Filing Details
- Accession Number:
- 0001209191-23-042247
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-13 20:28:20
- Reporting Period:
- 2023-07-11
- Accepted Time:
- 2023-07-13 20:28:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1324015 | William Jeffrey Henderson | C/O Fibrogen, Inc. 409 Illinois Street San Francisco CA 94158 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-07-11 | 2,000 | $2.69 | 32,866 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold by the reporting person pursuant to a 10b5-1 trading plan.
- Price reported is a weighted-average sales price. The shares were sold at prices ranging from $2.66 to $2.735. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
